◆Cellmat Therapeutics=Decision to proceed with a 1 billion KRW paid-in capital increase


◆Lotte Tour Development=Excluded from substantive review... Stock trading to resume on the 4th


◆Korea Kolmar=Acquisition of patents related to pressure dispersion components and pump containers


Hot Picks Today

About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column] About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]

◆Korea Special Steel=Decision to proceed with a 27.8 billion KRW paid-in capital increase


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing